GSS vs IDX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

54MEDIUM

IDX

INTEG DIAG FPO [IDX]

52MEDIUM

Score Breakdown

GSS IDX
Technical
50
40
Catalyst
65
58
Sentiment
50
50
Fundamental
59
100
Momentum
31
43
Risk Gate
50
34

Key Metrics

GSS Metric IDX
$14.5MMarket Cap$776.0M
877KAvg Volume (20d)872K
N/AShort Interest+1.4%
$0.43052-Week High$3.070
$0.05752-Week Low$1.905
-1.6%Daily Change-0.5%
$0.063Reference Price$2.070
-22.8%ROE+2.1%
-56.5%Profit Margin+1.8%

Active Signals

GSS Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (12 quarters)
Low P/S ratio (0.7x)
EPS estimates revised downward (-10pts)
Near 52-week low (2% of range)

IDX Signals

Stochastic turning bearish from a high level — caution
Knocking on the door of resistance — if it punches through, things could get interesting
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.0x)
Strong revenue growth (+56%)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare GSS and IDX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

GSS vs IMR →GSS vs IPD →GSS vs MYX →GSS vs NTI →GSS vs OCC →
GSS Full Analysis → IDX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).